Interface (Nasdaq: IFSIA) reported earnings on Oct. 24. Here are the numbers you need to know.

The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Interface missed estimates on revenues and missed estimates on earnings per share.

Compared to the prior-year quarter, revenue dropped and GAAP earnings per share dropped to a loss.

Gross margins contracted, operating margins grew, net margins shrank.

Revenue details
Interface reported revenue of $242.9 million. The seven analysts polled by S&P Capital IQ hoped for sales of $254.7 million on the same basis. GAAP reported sales were 11% lower than the prior-year quarter's $273.1 million.

Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.

EPS details
EPS came in at $0.19. The eight earnings estimates compiled by S&P Capital IQ averaged $0.22 per share. GAAP EPS were -$0.09 for Q3 against $0.19 per share for the prior-year quarter.

Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.

Margin details
For the quarter, gross margin was 34.1%, 50 basis points worse than the prior-year quarter. Operating margin was 9.8%, 50 basis points better than the prior-year quarter. Net margin was -2.4%, 690 basis points worse than the prior-year quarter.

Looking ahead
Next quarter's average estimate for revenue is $262.4 million. On the bottom line, the average EPS estimate is $0.23.

Next year's average estimate for revenue is $987.5 million. The average EPS estimate is $0.71.

Investor sentiment
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 102 members out of 120 rating the stock outperform, and 18 members rating it underperform. Among 42 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 39 give Interface a green thumbs-up, and three give it a red thumbs-down.

Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Interface is outperform, with an average price target of $15.58.